Oncology / CLL

Time-Limited Therapies for Younger, Fit Patients With Chronic Lymphocytic Leukemia

expert roundtables by Jennifer R. Brown, MD, PhD; Anthony Mato, MD, MSCE; and Susan O’Brien, MD

Younger, fit patients with chronic lymphocytic leukemia (CLL) are often interested in time-limited therapies such as fludarabine, cyclophosphamide,......READ MORE

CLL

Initial Treatment for Older (Age >70), Nonfrail Patients With Chronic Lymphocytic Leukemia

expert roundtables by Jennifer R. Brown, MD, PhD; Anthony Mato, MD, MSCE; and Susan O’Brien, MD

CLL

Risk Stratification for Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia

patient care perspectives by Anthony Mato, MD, MSCE

LATEST IN Oncology

Browse More Articles